@kewur 1 month ago
Everest Medicines hires former Moderna execs to lead mRNA cancer vaccine research
Everest Medicines hires former Moderna execs to lead mRNA cancer vaccine research
Everest Medicines just picked up two former Moderna scientists to lead their mRNA research teams. They brought on Lakshmi Srinivasan and Brandon Coder to help push their cancer vaccines through clinical trials and expand their US presence.
They have a Phase 1b trial planned for their EVM16 personalized cancer vaccine in Q4 2026, and they plan to submit it to the FDA in early 2027. Another off-the-shelf vaccine, EVM14, is expected to finish its Phase 1 study in Q1 2027.

finance.yahoo.com
| Everest Medicines Appoints Two Veteran mRNA Cancer Vaccine Scientists to Advance Global Clinical Development